Financials data is unavailable for this security.
View more
Year on year Plandai Biotechnology Inc grew revenues 221.30% from 92.90k to 298.49k while net income improved from a loss of 9.58m to a smaller loss of 4.38m.
Gross margin | -167.85% |
---|---|
Net profit margin | -1,381.50% |
Operating margin | -871.39% |
Return on assets | -66.54% |
---|---|
Return on equity | -- |
Return on investment | -- |
More ▼
Cash flow in USDView more
In 2016, cash reserves at Plandai Biotechnology Inc fell by 20.70k. Cash Flow from Financing totalled 1.19m or 399.82% of revenues. In addition the company used 1.07m for operations while cash used for investing totalled 132.57k.
Cash flow per share | -0.0211 |
---|---|
Price/Cash flow per share | -- |
Book value per share | -0.0422 |
---|---|
Tangible book value per share | -0.0422 |
More ▼
Balance sheet in USDView more
Current ratio | 0.0091 |
---|---|
Quick ratio | 0.0056 |
Total debt/total equity | -- |
---|---|
Total debt/total capital | 3.93 |
More ▼